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ABSTRACT
Genomic sequence comparisons between individ-
uals are usually restricted to the analysis of single
nucleotide polymorphisms (SNPs). While the interro-
gation of SNPs is efficient, they are not the only form
of divergence between genomes. In this report, we
expand the scope of polymorphism detection by
investigating the occurrence of double nucleotide
polymorphisms (DNPs) and triple nucleotide poly-
morphisms (TNPs), in which two or three consecu-
tive nucleotides are altered compared to the
reference sequence. We have found such DNPs
and TNPs throughout two complete genomes and
eight exomes. Within exons, these novel polymorph-
isms are over-represented amongst protein-altering
variants; nearly all DNPs and TNPs result in a
change in amino acid sequence and, in some
cases, two adjacent amino acids are changed.
DNPs and TNPs represent a potentially important
new source of genetic variation which may
underlie human disease and they should be
included in future medical genetics studies. As a
confirmation of the damaging nature of xNPs, we
have identified changes in the exome of a glioblast-
oma cell line that are important in glioblastoma
pathogenesis. We have found a TNP causing a
single amino acid change in LAMC2 and a TNP
causing a truncation of HUWE1.
INTRODUCTION
While all human genomes are extremely similar to one
another, there is variability that allows for the uniqueness
of each individual. This variability can take the form of
copy number variation, chromosomal rearrangements, or
nucleotide polymorphisms. The overwhelming majority of
recent studies of human variability have utilized micro-
array technology because of their relatively cheap cost
and ready availability. For example, Genome Wide
Association Studies (GWAS) have been performed for
numerous diseases (1), with varying levels of success. In
a GWAS study, numerous individuals with a speciﬁc
disease or trait and ethnically matched controls are
proﬁled using a microarray for single nucleotide poly-
morphisms (SNPs). SNP allelles that are more prevalent
in the aﬀected individuals relative to the controls are con-
sidered to be associated with illness. For a few diseases,
such as age related macular degeneration (2), common
SNPs with large eﬀects on risk have been identiﬁed. In
other cases, even when large sample sizes were utilized,
the risk alleles identiﬁed by GWAS were only able to
explain a small percentage of disease heritability (3).
One potential reason for the disappointing results of
GWAS studies is because of their limitation to SNPs.
The microarray platforms are designed to robustly
identify single nucleotide variations (4), but they are not
eﬀective in detecting variations involving more than
one consecutive nucleotide. If two sequences are
identical except for two adjacent nucleotides being
altered (e.g. one sequence has AC and the other
sequence has GT), this cannot be eﬀectively measured
using a microarray. Additionally, considerations regard-
ing DNA melting temperature and the exclusion of repeti-
tive sequences restrict the probes that can be used on a
microarray (5).
Recently, high-throughput DNA sequencing techniques
(6,7) have been developed and have begun to replace
microarrays for genome analysis studies (8). These
sequencing techniques are free of the single nucleotide
mismatch and melting temperature restrictions of micro-
arrays. In addition, sequencing can produce a more com-
prehensive picture of a genome, than the particular
features included on a given microarray. By analyzing
raw sequencing reads, multiple nucleotide polymorphisms
can be studied just as easily as SNPs.
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complete genomes, the Venter/HuRef Genome (9) and
the Chinese Genome (10), and eight complete exomes
(11), to analyze nucleotide polymorphism beyond the
single nucleotide level. We have aligned the sequencing
reads to the human reference genome and identiﬁed thou-
sands of loci with polymorphisms of 2 or 3nt. These poly-
morphisms are denoted as double nucleotide
polymorphisms (DNPs) and triple nucleotide polymorph-
isms (TNPs) (see Figure 1 for examples). For simplicity, as
a group, SNPs, DNPs and TNPs are identiﬁed as xNPs.
These xNPs do not include indels where nucleotides are
found to be inserted or deleted in one sequence relative to
another sequence. We focus on xNPs where the sequence
length remains the same, but one, two or three nucleotides
are changed. Indels in human genomes and exomes have
been extensively characterized in (12) and (11).
While SNPs are certainly an important source of vari-
ation between human genomes, there are a few reasons
why DNPs and TNPs have a greater propensity to be
involved in disease causing mutations. First, SNPs have
a strong propensity to be synonymous (13) whereby they
change the nucleotide sequence, but do not alter the amino
acid sequence due to the wobble allowed by the genetic
code. These synonymous changes are usually silent and do
not eﬀect the phenotype, but there are notable exceptions
(14,15). In contrast, a DNP or a TNP would eﬀect
multiple positions in a codon. Secondly, a SNP can at
most result in the change of one amino acid, whereas a
DNP or a TNP can change the residue at two adjacent
positions and cause a more dramatic change.
Before looking for the xNPs in genomic sequence, we
ﬁrst computationally determined their predicted eﬀects on
amino acid sequence under an assumption of randomness
(Table 1). For example, given all possible permutations of
nucleotides in a codon, 24% of SNPs would be expected
to result in a synonymous mutation due to nonspeciﬁcity
in the genetic code. On the other hand, a DNP or a TNP
would randomly produce a synonymous mutation only 9
or 0.4% of the time, respectively. The rare possibility of a
synonymous TNP can only occur when it overlaps two
codons and changes both of them in a way that they
still code for the same amino acid. As also displayed in
Table 1, when a DNP causes an amino acid change, it is
much more likely to be a single change rather than
a double. Similarly, a TNP has a greater chance of
causing one amino acid change than two changes, but
the ratio is smaller. These theoretical results support the
premise that DNPs and TNPs can be important sources of
genomic variation, and our analysis of real data will be
compared against these predicted results.
We have found that in the human genome there is a
considerable amount of variation with regard to DNPs
and TNPs. For the two complete genomes that we
analyzed, we found tens of thousands of DNPs and thou-
sands of TNPs throughout the genome. As with all
genomic variation, the majority of this variation was
found outside of coding regions. Even so, a substantial
amount of xNPs are found within coding exons and they
have a strong potential to be involved in disease path-
ology. In order to test this hypothesis, we have applied
our technique to the analysis of an exome from a glioblast-
oma cell line. In this exome, we have found xNPS causing
amino acid changes and a truncated protein in genes
whose mis-expression have been previously found in
glioblastoma.
MATERIALS AND METHODS
Theoretical calculations
For SNPs, each codon was iterated through, and each
position in the codon was changed to one of the three
possible diﬀerent nucleotides. The percentage of changes
that caused amino acid changes or no change were tallied.
For DNPs and TNPs, two adjacent codons were used and
every possible set of two (for DNP) and three (for TNP)
changes were performed. In order to allow for the
querying of each position in each codon, the last positions
of the second codon were wrapped onto the ﬁrst codon.
To illustrate, the six positions in the two codons from 50 to
30 will be listed as integers from 1 to 6, such that the list of
TNPs is: 123, 234, 345, 456, 561, 612.
Sequencing data and alignment
The Chinese genome data was obtained from (10) as raw
FASTQ sequencing reads and only those paired ended
reads that were 35bp in length were used in the analysis.
The Venter/HuRef raw sequencing reads were obtained
from (9). Since these sequencing reads were from an
Table 1. Theoretical calculations of the percentages of each type of change that will be cause by SNPs, DNPs and TNPs
Type of xNP Number of
nucleotides
changed
Percentage of xNPS
resulting in the
same amino acids, %
Stop codon read
through (from stop
to coding), %
Percentage of changes
resulting in stop codons
(premature stop), %
Percentage of XNPs resulting
in the change of:
1 Amino acid, % 2 Amino acids, %
SNPs 1 24 4 4 68 N/A
DNPs 2 0.90 7 6 78 8
TNPs 3 0.40 8 7 51 33
Figure 1. An example of a SNP, a DNP and a TNP between two DNA
sequences.
Nucleic Acids Research, 2010,Vol.38, No. 18 6103Applied Biosystems 3730xl they were much longer than
36-bp Illumina reads. To allow for comparison, the long
reads were cut into non-overlapping 3-bp reads. The eight
exome sequences were from (11). The glioblastoma exome
sequence was from (16).
The sequences were aligned using the Bowtie (17) align-
ment program and three mismatches were allowed. The
reference genome used was hg18. The consensus repeat
elements were taken from the UCSC genome browser an-
notations (18) and the genes used were the CCDS gene set
(19).
xNP determination
After the reads were aligned to the genome, any single
base mismatch was counted as a putative SNP and two
or three consecutive mismatches within reads were marked
as putative DNPs or TNPs respectively. For each putative
xNP, the number of sequencing reads coding for the xNP
or the reference sequence were tallied. The following
criteria were used for calling an xNP: if there were no
reads matching the reference at that position, there
needed to be a minimum of three reads supporting the
xNP, and the xNP would be called as homozygous. If
there were reads matching the reference, two requirements
needed to be met to call a heterozygous xNP: First, there
needed to be at least three xNP supporting reads at that
location. Second, a binomial distribution was computed at
each genomic position, based on the total number of reads
at that location and a 50% allele probability. A heterozy-
gous xNP was called if the number of xNP-reads was at
least half of the total number of reads at that location
minus twice the standard deviation of the binomial distri-
bution. This threshold allowed for <5% false negative
rate of calling heterozygotes.
Analysis
The functional categorization of genes with xNPs was per-
formed using DAVID (20). The lethality analysis of the
xNPs was performed using Polyphen version 1.1.7 (21)
and SIFT version 4.0.3 (22). Additionally, we analyzed
the xNPs using PANTHER version 6.1 (23). For a
substantial number of the polymorphisms, PANTHER
was not able to give a prediction of the probability of it
being deleterious. This is because the amino acid substitu-
tion occurred in a part of the protein that was not covered
by the multi-sequence alignments underlying the predic-
tions. This is a known shortcoming of PANTHER (23).
Overall, the percentages of polymorphisms predicted to be
deleterious by PANTHER were much lower than the per-
centages from both Polyphen and SIFT. A strong cause of
this was polymorphisms not being scored and therefore
not having a possibility of being predicted to be
damaging. We therefore have not reported the
PANTHER predictions.
RESULTS
Determination of xNPs in the genomes
In order to analyze xNPs in complete human genomes, we
selected the Venter (9) and the Chinese (10) genomes as
examples for our analysis. The sequencing reads for each
of the genomes were aligned to the genome reference hg18
(‘Materials and methods’ section). For each alignment, up
to three mismatches were allowed in order to capture
SNPs, DNPs or TNPs. Any two adjacent mismatches
were marked as a DNP; while three adjacent mismatches
indicated a TNP.
The number of xNPs found throughout the genome and
their locations are shown in Table 2. For each genome and
type of xNP, the total number of xNPs and the number
that are homozygous are listed. Since the SNPs for these
two genomes have been previously determined, we
compared our results to the published counts. For the
Venter genome, 3.2 million SNPs were reported (9), as
compared to our ﬁnding of 2.89 million SNPS. The
Chinese genome was reported to have 3.07 million SNPs
(10), while our method yielded 3.69 million. It should be
noted that these diﬀerences in SNP counts are in the
expected directions, given the diﬀerent alignment and
SNP calling techniques and thresholds that were utilized
(‘Discussion’ section).
Table 2. Genome-wide distribution of SNPs, DNPs and TNPs for the Chinese and Venter Genomes
xNP location Chinese SNPs Venter SNPs Chinese DNPs Venter DNPs Chinese TNPs Venter TNPs
Total Homozygous Total Homozygous Total Homozygous Total Homozygous Total Homozygous Total Homozygous
Downstream of
Genes 5kb
103004 39296 75988 40143 1277 436 935 360 92 41 50 24
Introns 904259 367472 695131 378275 9898 3646 7260 2978 823 334 469 179
Upstream of
genes 5kb
102359 39096 75803 39814 1187 423 925 380 100 39 59 29
Exons 25381 7935 15079 8042 164 48 127 45 3 1 6 1
Intergenic 2547066 1015539 2032962 1030241 32947 10460 27454 8974 2154 767 1362 406
Total xNPs 3682069 1469338 2894963 1496515 45473 15013 36701 12737 3172 1182 1946 639
Consensus
repeats
1740523 627051 1413418 650635 23384 6469 21661 5848 1304 461 1055 265
6104 Nucleic Acids Research, 2010,Vol.38, No. 18Overall, the numbers of DNPs and TNPs are greatly
reduced relative to the numbers of SNPs. This is
expected because the production of a DNP or a TNP
requires the mutation of two or three adjacent nucleotides
whereas a SNP only requires one change. For all of the
xNPs, the greatest percentage occurs in intergenic regions,
followed by introns, both of which are non-coding and are
expected to have relatively lower levels of consistency
across individuals. In contrast, far less than 1% of xNPs
occur in coding exons, which are under selective pressure
to prevent amino acid mutations. TNPs are almost com-
pletely absent from coding exons and there are only three
coding TNPs from the Chinese genome and six from the
Venter genome. Approximately half of all xNPs were
observed in portions of the genome that are deﬁned as
repeats by RepeatMasker (24); this is expected since
such regions cover 45% of the human genome (25).
xNPs within coding exons
Since coding exons are important regions of the genome
for protein production, we focused on the analysis of
xNPs in these regions. The xNPs were classiﬁed according
to whether they caused no amino acid change (neutral/
synonymous), caused one amino acid change, caused
two amino acid changes, changed from a stop codon to
a coding codon (read-through), or changed from a coding
amino acid to a stop codon (premature stop). These
results are shown in Table 3, and a complete list of each
gene that had any xNPs along with the change produced
by each type of xNP is shown in Supplementary Table S1.
We ﬁrst compared the results with the theoretical cal-
culations from Table 1. For the SNPs, a lower percentage
resulted in amino acid changes than would be predicted at
random. Theoretically, 68% of SNPs should change one
amino acid, whereas this was found for 58 and 47% of the
SNPs in the Chinese genome and the Venter genome re-
spectively. This decrease was caused by a greater than
predicted number of synonymous SNPs. We predicted
that there would be 24% synonymous SNPs and we
found that 41 and 53% of the Chinese and Venter
genome SNPs, respectively, were synonymous. For both
genomes, the synonymous to non-synonymous SNP ratio
is around 50–50, as has been previously found for the
genomes of multiple species (26–28).
In contrast to the bias from the calculations towards
synonymous SNPs, we found a strong bias towards
non-synonymous DNPs. For both genomes almost all of
the exonic DNPs resulted in an amino acid change. The
theoretical calculations predicted 86% of the DNPs
causing amino acid changes and we found 98% of the
DNPs for each genome causing a change. There were
only a small number of exonic TNPs, but these were com-
pletely non-synonymous.
For all types of xNPs, the occurrence of both premature
stop codons and stop codon read-through was less than
predicted. For example, while 7% of DNPs were predicted
to change a stop codon to a coding codon and result in
stop codon read-through; neither genome had any DNPs
producing read-through. Premature stop codons were pre-
dicted to result from 4 to 6% of SNPs and DNPs, but they
were only found in 2% or less of all such events. These
ﬁndings are presumably due to selective pressure against
the potentially catastrophic results of either a protein trun-
cation or elongation.
Analysis of exonic DNPs and TNPs
We found a 225 DNPs located within 200 genes in the
Venter and Chinese genomes. Sixty-six (29.3%) of these
Table 3. Eﬀects of SNPs, DNPs and TNPs within the genes of the Chinese and Venter Genomes
Type of change Chinese SNPs Venter SNPs Chinese DNPs Venter DNPs Chinese TNPs Venter TNPs
1 Amino acid change
Number 14784 7092 152 114 0 6
Percentage of changes 58 47 93 90 0 100
Number of genes aﬀected 7841 4407 141 98 0 6
2 Amino acid changes
Number N/A N/A 8 10 3 0
Percentage of changes N/A N/A 5 8 100 0
Number of genes aﬀected N/A N/A 8 10 3 0
Read through (from stop to coding)
Number 24 6 0 0 0 0
Percentage of changes 0.09 0.04 0.00 0.00 0.00 0.00
Number of genes aﬀected 23 6 0 0 0 0
No change
Number 10346 7925 0 2 0 0
Percentage of changes 41 53 0 2 0 0
Number of genes aﬀected 6211 5002 0 2 0 0
Premature stop codon
Number 227 56 4 1 0
Percentage of changes 0.89 0.37 2 0.79 0.00 0.00
Number of genes aﬀected 217 50 4 1 0
Total 25381 15079 164 127 3 6
Nucleic Acids Research, 2010,Vol.38, No. 18 6105DNPs are found in both genomes, and may reﬂect the
presence of variants or errors in the reference genome.
In both the Venter and Chinese genomes, over 90% of
the DNPs resulted in a single amino acid change. For
the Venter genome, 30% of them were predicted to me
damaging by both Polyphen (21) and SIFT (22). For the
Chinese genome, 35% were predicted by Polyphen to be
damaging while 34% were predicted to be deleterious by
SIFT. We then used DAVID (20) to functionally annotate
the genes containing DNPs. For the Chinese genome, the
top Gene Ontology category to describe the DNPs was for
the MHC protein complex (Benjamini corrected
P=0.032) and for the Venter genome, no categories
were found to be signiﬁcant.
Both genomes had a small number of TNPs within their
exons, with the Venter genome only containing six exonic
TNPS and the Chinese genome only containing three
exonic TNPs. None of these TNPs are shared between
the two genomes. For the Venter exonic TNPs, only one
is homozygous, but they all cause a single amino acid
change. For these TNPs, four of them are predicted by
Polyphen to be either damaging to the protein structure,
while two are predicted to be deleterious by SIFT. For the
Chinese TNPs, only one is homozygous, but all cause two
amino acid changes. Since Polyphen and SIFT only look
at single amino acid changes, we were unable to evaluate
the double nucleotide changes for their damaging poten-
tial. These TNPs were not concentrated in proteins of one
type and include proteins that are structural (RDX,
KRTAP10-1), signal regulatory (SIRPA), RNA binding
(GPATC4), an olfactory receptor (OR5L2), bind to
protein kinase A (AKAP3), a metalloprotease
(ADAMTS9) and an antigen presenter (HLA-DRB5).
xNPs in sequenced exomes
To further investigate the occurrence of xNPs in human
genes and their consistency, we utilized complete exome
sequencing data from eight individuals (11). Since only the
exomes of these individuals were sequenced, we were not
able to quantify xNPs outside of genes. The SNPs, DNPs
and TNPs in each exome were determined using the same
criteria that were used for our initial two genomes (Venter
and Chinese) and the results are shown in Table 4. For
each of these exomes, we found an average of 17164
exonic SNPs per exome which is very close to the
reported count (11) of 17272. We found a smaller
number of DNPs and TNPs, with an average of 164
DNPs per exome and ﬁve TNPs per exome. Notably,
the average number of exonic DNPs was identical to
that observed in the Chinese genome, which was
sequenced on the same platform (Illumina). We then
looked at the pervasiveness of each xNP among the
eight exomes (Supplementary Table S2). On average the
same SNP, DNP or TNPs was found in 2.5, 1.8 and 1.4
exomes respectively. Despite this low average, there were
SNPs and DNPs that were found across all eight exomes.
For these loci, the occurrence of a SNP or a DNP relative
to the reference genome in eight samples indicates that the
reference genome probably does not contain the most
common sequence. This is the case for 1450 SNPs
T
a
b
l
e
4
.
E
ﬀ
e
c
t
s
o
f
S
N
P
s
,
D
N
P
s
a
n
d
T
N
P
s
i
n
t
h
e
e
i
g
h
t
s
e
q
u
e
n
c
e
d
e
x
o
m
e
s
T
y
p
e
o
f
c
h
a
n
g
e
N
A
1
2
1
5
6
N
A
1
2
8
7
8
N
A
1
8
5
0
7
N
A
1
8
5
1
7
N
A
1
8
5
5
5
N
A
1
8
9
5
6
N
A
1
9
1
2
9
N
A
1
9
2
4
0
A
v
e
r
a
g
e
S
N
P
S
D
N
P
S
T
N
P
s
S
N
P
S
D
N
P
S
T
N
P
s
S
N
P
s
D
N
P
S
T
N
P
s
S
N
P
s
D
N
P
S
T
N
P
s
S
N
P
s
D
N
P
S
T
N
P
s
S
N
P
s
D
N
P
S
T
N
P
s
S
N
P
s
D
N
P
S
T
N
P
s
S
N
P
s
D
N
P
S
T
N
P
s
S
N
P
s
D
N
P
S
T
N
P
s
1
A
m
i
n
o
a
c
i
d
C
h
a
n
g
e
N
u
m
b
e
r
7
6
0
4
1
4
1
4
7
2
2
8
1
5
8
4
8
5
4
0
1
5
0
5
8
6
8
5
1
7
0
5
7
3
5
0
1
2
1
5
7
0
7
3
1
5
4
1
8
3
5
5
1
6
9
5
8
3
8
5
1
7
2
2
7
9
0
3
1
5
4
4
P
e
r
c
e
n
t
a
g
e
o
f
c
h
a
n
g
e
s
4
7
9
4
8
0
4
7
9
3
8
0
4
6
9
4
8
3
4
6
9
7
6
3
4
6
9
4
8
3
4
6
9
2
1
0
0
4
5
9
1
1
0
0
4
6
9
6
1
0
0
4
6
9
4
8
6
N
u
m
b
e
r
o
f
g
e
n
e
s
a
ﬀ
e
c
t
e
d
4
7
5
8
1
3
2
3
4
5
6
3
1
5
3
4
5
2
3
0
1
4
1
3
5
2
2
9
1
5
4
5
4
6
7
2
1
1
7
5
4
5
1
5
1
4
3
1
5
1
4
5
1
5
4
4
5
2
0
8
1
6
2
2
4
9
1
5
1
4
5
3
2
A
m
i
n
o
a
c
i
d
C
h
a
n
g
e
s
N
u
m
b
e
r
N
/
A
5
1
N
/
A
7
1
N
/
A
6
1
N
/
A
3
3
N
/
A
5
1
N
/
A
9
0
N
/
A
9
0
N
/
A
8
0
N
/
A
7
1
P
e
r
c
e
n
t
a
g
e
o
f
c
h
a
n
g
e
s
N
/
A
3
2
0
N
/
A
4
2
0
N
/
A
4
1
7
N
/
A
2
3
8
N
/
A
4
1
7
N
/
A
5
0
N
/
A
5
0
N
/
A
4
0
N
/
A
4
1
4
N
u
m
b
e
r
o
f
g
e
n
e
s
a
ﬀ
e
c
t
e
d
N
/
A
5
1
N
/
A
7
1
N
/
A
6
1
N
/
A
3
3
N
/
A
5
1
N
/
A
9
0
N
/
A
9
0
N
/
A
8
0
N
/
A
7
1
R
e
a
d
t
h
r
o
u
g
h
(
f
r
o
m
S
t
o
p
t
o
C
o
d
i
n
g
)
N
u
m
b
e
r
1
0
0
0
7
0
0
1
7
1
0
1
2
0
0
8
0
0
4
0
0
9
0
0
1
0
0
0
1
0
0
0
P
e
r
c
e
n
t
a
g
e
o
f
c
h
a
n
g
e
s
0
0
0
0
0
0
0
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
.
0
6
0
0
N
u
m
b
e
r
o
f
g
e
n
e
s
a
ﬀ
e
c
t
e
d
1
0
0
0
7
0
0
1
7
1
0
1
2
0
0
8
0
0
4
0
0
9
0
0
1
0
0
0
1
0
0
0
N
o
C
h
a
n
g
e
N
u
m
b
e
r
8
5
7
8
3
0
8
2
6
6
2
0
9
9
9
4
2
0
1
0
1
4
1
1
0
8
5
6
5
2
0
8
1
4
9
2
0
1
0
1
7
0
5
0
9
8
3
3
0
0
9
2
1
2
2
0
P
e
r
c
e
n
t
a
g
e
o
f
c
h
a
n
g
e
s
5
3
2
0
5
3
1
0
5
4
1
0
5
4
1
0
5
4
2
0
5
3
1
0
5
5
3
0
5
4
0
0
5
4
1
0
N
u
m
b
e
r
o
f
g
e
n
e
s
a
ﬀ
e
c
t
e
d
5
3
9
7
3
0
5
2
2
0
2
0
6
1
3
9
2
0
6
2
4
0
1
0
5
3
6
5
2
0
5
2
1
6
2
0
6
2
6
5
5
0
6
0
9
4
0
0
5
7
4
2
2
0
P
r
e
m
a
t
u
r
e
S
t
o
p
C
o
d
o
n
N
u
m
b
e
r
3
9
1
0
4
2
2
0
3
5
0
0
4
3
2
0
3
5
1
0
3
8
2
0
4
5
2
0
4
2
0
0
4
0
1
0
P
e
r
c
e
n
t
a
g
e
o
f
c
h
a
n
g
e
s
0
1
0
0
1
0
0
0
0
0
1
0
0
1
0
0
1
0
0
1
0
0
0
0
0
.
2
3
1
0
N
u
m
b
e
r
o
f
g
e
n
e
s
a
ﬀ
e
c
t
e
d
3
8
1
0
4
2
2
0
3
4
0
0
4
2
2
0
3
3
1
0
3
7
2
0
4
4
2
0
4
1
0
0
3
9
1
0
T
o
t
a
l
E
x
o
n
i
c
x
N
P
S
1
6
2
3
1
1
5
0
5
1
5
5
4
3
1
6
9
5
1
8
5
8
6
1
5
9
6
1
8
8
8
1
1
7
6
8
1
5
9
5
8
1
2
9
6
1
5
2
6
4
1
6
7
1
1
8
5
7
9
1
8
5
5
1
8
2
7
0
1
8
0
2
1
7
1
6
4
1
6
4
5
6106 Nucleic Acids Research, 2010,Vol.38, No. 18(8.4%) and 18 DNPs (11%). These low percentages of
pervasive xNPS indicate that the majority of xNPS are
true variations between genomes rather than reﬂecting
inaccuracies in the reference genome.
The most common TNP was found in four exomes in
KRTAP10-1 gene and it was determined by Polyphen and
SIFT to be a benign change. As with the TNPs found in
the two full genomes, a signiﬁcant amount of them result
in the change of two adjacent amino acids which cannot
be easily evaluated.
To further conﬁrm the ﬁndings of xNPs in the exomes,
we compared our ﬁndings for one exome (NA19240) to
the complete genome of that individual that has recently
been completed using the Complete Genomics technology
(29). In our analysis of the data from the exome
sequencing (Table 4), we identiﬁed 180 DNPs and two
TNPs in coding regions; while using the Complete
Genomics data, we identiﬁed 155 coding DNPs and ﬁve
coding TNPs. Seventy of the DNPs and one of the TNPs
were found using both techniques. Thus, results of xNP
analysis could be to some extent be dependent upon
sequencing platform. At the same time, the overall abun-
dance of DNPs and TNPs observed in the human genome
and exome appear to be relatively consistent across
various sequencing technologies.
We then looked at the positions within codons where
xNPs occur. SNPs should preferentially occur in the third
codon position, as has been previously found (26,30). This
is because of the wobble nature of the genetic code
whereby a change in this position is often silent. DNPs
and TNPs have not been previously proﬁled, but it is
expected that a DNP would preferentially occur in either
positions 1 and 2 or 2 and 3 of a codon so as not to
overlap two codons. Similarly, TNPs would be expected
to completely overlap an individual codon. A plot of each
type of xNP and the percentage that begin in each position
in a codon is shown in Figure 2. As expected, the largest
percentage of SNPs occur in the third codon position, but
this was not an overwhelming majority (43%). For DNPs,
unexpectedly, there appears to be little preference for any
codon position. For TNPs, there is a bias towards their
beginning in the ﬁrst codon position (54%) and covering a
single codon rather than overlapping two adjacent codons.
Nucleotide substitutions can be categorized as either
transitions or transversions depending upon the 2nt
involved. There is generally considered to be a strong
bias of transitions as compared to transversions in
metazoan genomes (31). This was conﬁrmed by our
ﬁndings for SNPs in the combined set of eight exomes.
There were 37457 transitions and 14792 transversions
observed. For DNPs, and TNPs, the terms of transition
and transversions do not directly apply since they are
associated with individual nucleotides. Nevertheless, we
were able to investigate the positions within a DNP or a
TNP as transition or transversions (Table 5). For DNPs,
the ﬁrst position was dominated (66%) by a transition,
while there was much less preference at the second
position. In contrast, there was a preference among
TNPs (46%) for three transversions in a row.
xNPs in a cancerous exome
Finally, we applied our analysis to the sequenced exome of
the U87 glioblastoma cell line (16). Rather than
sequencing a complete exome, this study only sequenced
the exons of 5253 cancer associated genes. Using our
analysis, we found 53 DNPs and eight TNPs. For the
DNPs, four caused a double amino acid change. Of the
Table 5. A Tally of each combination of nucleotide changes for DNPs and TNPs
DNPs TNPs
Changes Count Changes Count
Transition–Transition 249 Transition–Transition–Transition 1
Transition–Transversion 256 Transition–Transition–Transversion 2
Transversion–Transition 111 Transition–Transversion–Transition 1
Transversion–Transversion 147 Transition–Transversion–Transversion 3
Transversion–Transition–Transition 4
Transversion–Transition–Transversion 2
Transversion–Transversion–Transition 2
Transversion–Transversion–Transversion 13
Figure 2. The percentage SNPs, DNPs and TNPs that begin in each
codon position.
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predicted by Polyphen to be damaging while SIFT
determined that 31% would be deleterious. For the
TNPs, four caused a double amino acid change and
three that caused a single amino acid change. Of the
single amino acid changes, all of them were predicted by
both Polyphen and SIFT to be damaging. In addition, one
TNP caused a premature stop codon in this exome. A
summary of the mutations found in each gene are shown
in Table 6.
In order to determine whether any of these xNPs
were in genes that have been previously found to be
related to glioblastoma, we conducted Pubmed searches
for each of the genes that was found to have a
damaging xNP, or an xNP changing the location
of a stop codon. We found that a TNP in the LAMC2
gene that results in a single amino acid change L952D
which is predicted to be damaging. This gene has been
found to be ampliﬁed in glioblastomas (32) as well as
other cancers (33,34). A TNP in the HUWE1 gene
Table 6. A summary of the DNPs and TNPs found in the glioblastoma U87 exome
DNPs TNPs
CCDS Name Gene Name Result of xNP CCDS Name Gene Name Result of xNP
CCDS10326 ADAMTSL3 1 Amino acid change CCDS11966 ALPK2 1 Amino acid change
CCDS10411 PIGQ 1 Amino acid change CCDS1352 LAMC2 1 Amino acid change
CCDS11509 CDC27 1 Amino acid change CCDS4452 RASGEF1C 1 Amino acid change
CCDS12096 ZNF555 1 Amino acid change CCDS11905 FAM59A 2 Amino acid change
CCDS13754 PRODH 1 Amino acid change CCDS2012 PROM2 2 Amino acid change
CCDS14006 ST13 1 Amino acid change CCDS34698 ZKSCAN1 2 Amino acid change
CCDS14228 DMD 1 Amino acid change CCDS7328 PPP3CB 2 Amino acid change
CCDS14596 ZBTB33 1 Amino acid change CCDS35301 HUWE1 Premature stop codon
CCDS14607 STAG2 1 Amino acid change
CCDS14711 CSAG1 1 Amino acid change
CCDS14713 MAGEA2 1 Amino acid change
CCDS2057 IL1RL1 1 Amino acid change
CCDS2397 BARD1 1 Amino acid change
CCDS30824 PDE4DIP 1 Amino acid change
CCDS30947 ABL2 1 Amino acid change
CCDS31702 OR10G4 1 Amino acid change
CCDS32595 KIAA0100 1 Amino acid change
CCDS33119 NLRP13 1 Amino acid change
CCDS33432 TCF15 1 Amino acid change
CCDS33539 SYNJ1 1 Amino acid change
CCDS33876 MED12L 1 Amino acid change
CCDS34389 CDSN 1 Amino acid change
CCDS34654 TRIM50 1 Amino acid change
CCDS35277 SHROOM4 1 Amino acid change
CCDS35277 SHROOM4 1 Amino acid change
CCDS35305 FAM104B 1 Amino acid change
CCDS35417 MAGEC1 1 Amino acid change
CCDS35431 PASD1 1 Amino acid change
CCDS42086 LRRK1 1 Amino acid change
CCDS42437 MAPK4 1 Amino acid change
CCDS42535 ZNF626 1 Amino acid change
CCDS42959 KRTAP10-6 1 Amino acid change
CCDS42965 KRTAP12-2 1 Amino acid change
CCDS42965 KRTAP12-2 1 Amino acid change
CCDS43248 DSPP 1 Amino acid change
CCDS44016 MAGEA2B 1 Amino acid change
CCDS4881 CUL7 1 Amino acid change
CCDS6415 CYC1 1 Amino acid change
CCDS7148 MYO3A 1 Amino acid change
CCDS7566 DUSP5 1 Amino acid change
CCDS7693 NLRP6 1 Amino acid change
CCDS7927 DDB2 1 Amino acid change
CCDS7954 PRG3 1 Amino acid change
CCDS9300 SACS 1 Amino acid change
CCDS9737 DAAM1 1 Amino acid change
CCDS9766 HSPA2 1 Amino acid change
CCDS9867 SNW1 1 Amino acid change
CCDS9928 SERPINA5 1 Amino acid change
CCDS9998 JAG2 1 Amino acid change
CCDS11281 CCL13 2 Amino acid change
CCDS14446 FAM46D 2 Amino acid change
CCDS4269 PCDH12 2 Amino acid change
CCDS5989 DLC1 2 Amino acid change
6108 Nucleic Acids Research, 2010,Vol.38, No. 18causes a truncation of the protein by the insertion of a
premature stop codon reducing its length from 4374
residues to 1668 residues. The HUWE1 gene has been
found to be important in brain development, and its
deletion has been found to be important in malignant
brain tumors (35). In the case of this cell line, HUWE1
is not deleted, but it is truncated and therefore most likely
not functional.
DISCUSSION
We have characterized a novel source of genomic vari-
ation, DNPs and TNPs, which occur with a frequency
of  1% of the total number of SNPs. In the two
genomes we examined, we found tens of thousands of
DNPs and thousands of TNPS. While only a small per-
centage of these changes are found in coding sequence and
directly aﬀect the transcribed protein, the non-exonic
xNPs could of course be located in regulatory regions.
Although not directly examined in this report, alteration
of sequence in a promoter or an enhancer could change
the expression dynamics of the associated gene (36).
The coding xNPs, while small in number, could be very
important clinically. In order to cause a disease, only a
single amino acid change in the genome may be required.
Since DNPs and TNPs cause an amino acid change in at
least 90% of instances, they could very easily be a cause of
a disease. Those DNPs and TNPs that cause two amino
acid changes are especially intriguing since they are likely
to have a pronounced aﬀect on the protein structure and
function. Exonic DNPs and TNPs are approximately
3-fold over-represented amongst amino acid-changing
polymorphisms and produce greater than 100 such
changes in each normal human genome.
Based upon the average frequency of SNPs and simple
probability, DNPs and TNPs should be much rarer than
what we found. Assuming the occurrence of a SNP to be
 1 in 1000bp (3 million SNPs in a 3 billion base genome)
and assuming independence of all SNPs, there should be
one DNP every 1 million base pairs (1000
2), which would
total 3000 DNPs in the entire human genome. There
should also be one TNP every 1 billion base pairs
(1000
3) which would total three TNPs for the entire
human genome. These numbers are vastly lower than
the numbers that we observed, supporting the idea that
the mutations in a DNP or a TNP are not independent. It
has been found that SNPs tend to cluster along the
genome rather than being evenly distributed; certain
regions of the genome have large amounts of SNPs and
other regions of the genome are devoid of SNPs (37).
Given a region of the genome with a large amount of
SNPs, it is statistically more likely that a DNP or TNP
would occur. The occurrence of DNPs and TNPs (as well
as clusters of nearby, though non-adjacent SNPs) can be
explained by results of polymerase mis-incorporation ex-
periments. In these assays, it was found that if a polymer-
ase incorporates the incorrect nucleotide at a particular
location, it increases the likelihood that another nearby
nucleotide will be incorporated incorrectly (38,39).
In considering our results, it is important to recognize
that the number of variants identiﬁed by sequencing can
vary as a function of numerous factors, including
sequencing platform, read length, depth of coverage, and
read alignment parameters (including quality control
ﬁlters). The present study utilized diﬀerent alignment par-
ameters from prior whole genome sequencing studies, in
order to permit detection of DNPs and TNPs. For
example, the Chinese genome (10) was aligned to the ref-
erence using the SOAP (40) tool and the paired-end reads
were aligned together allowing for two mismatches in each
read. In our analysis, we aligned all of the reads using
Bowtie (17), because it is very fast at aligning reads and
this speed can be further increased by allowing it to use
multiple threads on a multiprocessor machine (41).
Moreover, we permitted up to three mismatches in each
read in order to be able to detect TNPs; if we had used the
standard cutoﬀ of two mismatches, any read providing
evidence for a TNP would have been discarded as an
unmappable read. Given this less stringent ﬁlter, it is not
surprising that we identiﬁed a somewhat larger number of
SNPs in the Chinese genome than originally reported
(Wang et al. 2008). By contrast, the eight exomes were
originally aligned using Maq (Li et al. 2008a) which
does not have an explicit cutoﬀ for the number of
mismatches allowed; our alignment procedures resulted
in an average number of SNPs that was nearly identical
to the original report (Shendure et al. 2009). Finally, the
original Venter genome analysis (9,42) was based upon the
traditional Sanger sequencing and assembly of the Venter
genome (43). As such, the SNPs between this genome and
the human reference genome were determined by
comparing the two genome assemblies de novo. Our
analysis of the Venter/HuRef genome was completely dif-
ferent in that we utilized their raw sequencing reads which
were truncated into non-overlapping 36-bp reads to
simulate Ilumina sequencing reads (‘Materials and
Methods’ section). This procedure resulted in a slight
under-estimate of the total number of SNPs compared
to the Venter Institute report, presumably due to some
variation in regions with low-depth of coverage failing
to meet our criteria for SNP calling.
As an application of our technique to a real disease, we
investigated the U87 glioblastoma cell line. We found two
TNPs that cause pathogenic changes in genes that have
already been implicated in the disease. Besides these mu-
tations, it is very likely that a further understanding of
glioblastoma could be gained from an analysis of the
xNPs that were found in genes that have not already
been suspected of involvement in glioblastoma.
CONCLUSION
In conclusion, the detection of DNPs and TNPs has not
been previously studied, to our knowledge, and would be
impractical using microarrays. With the recent advent of
high-throughput sequencing and the possibility of
sequencing complete exomes (11) and genomes (29), the
investigation of DNPs and TNPs should be relatively
straightforward. Their identiﬁcation could be
Nucleic Acids Research, 2010,Vol.38, No. 18 6109computationally accomplished in a manner as SNPs are
called in sequenced genomes. It is hoped that the investi-
gation of DNPs and TNPs in genomes will lead to the
identiﬁcation of causative mutations for genetic diseases
that have thus far eluded SNP-based studies.
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